Broadly Neutralizing Antibodies for HIV Prevention, Therapy and Cure

Marina Caskey, MD
Associate Professor of Clinical Investigation
The Rockefeller University, New York, NY



CME VIDEOTop of page

About the Presenter: Top of page

Marina Caskey is an Associate Professor of Clinical Investigation at The Rockefeller University and an attending physician in infectious diseases at New York Presbyterian-Weill Cornell Medical Center. Her research in broadly neutralizing antibodies have revitalized this area of HIV research, which are now considered one of the most promising strategies to achieve HIV remission, as well as potential alternatives to antiretrovirals for both therapy and prevention of HIV disease.

Learning Objectives: Top of page

At the completion of this educational session, learners will:
  • Better understand the challenges to HIV eradication.
  • Be aware of current immunologic approaches to treat, eradicate or prevent HIV infection.
  • Know the results of recent clinical trials of HIV immunotherapy and implications for future studies.

CME Information: Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ on September 17, 2019 and will terminate September 16, 2022.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
  • Accreditation Statement: Top of page


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

    The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

    Disclosure Statement: Top of page


    Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Marina Caskey (Presenter) had no relevant financial relationships to disclose. Dr. Caskey submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.
  • Financial Support: Top of page

    This PRN CME activity is funded in part by unrestricted educational grants from: Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.

    How to Obtain CME Credit: Top of page

    To obtain CME credit for this PRN program, please visit the PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.

    You must be logged in to post a comment. Login | Register